Back to search

Article

SLC16A13 functions as a novel oncogenic driver in glioma by impairing monocarboxylate transport and mitochondrial redox homeostasis

2026-07-13

Abstract excerpt

<title>Abstract</title> <p> Background Gliomas are the most prevalent primary malignant brain tumors, and effective therapeutic targets remain limited. Solute carrier family 16 member 13 (SLC16A13), a monocarboxylate transporter implicated in metabolic regulation, has not been characterized in glioma biology. Methods This study systematically investigated SLC16A13 expression and clinical relevance using The Ca...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
67da6ca7-4024-58f2-81ff-9c9f97b1d93c
DOI
10.21203/rs.3.rs-10260676/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SLC16A13 functions as a novel oncogenic driver in glioma by impairing monocarboxylate transport and mitochondrial redox homeostasisDOI 10.21203/rs.3.rs-10260676/v1
Select a neighboring publication to make it the new centre.